SCHEMBL13610467

SCHEMBL13610467

c1ccc(CSSSCc2ccco2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.51
CYP2D6 P10635 2/20 0.51
ALDH1A1 P00352 9/20 0.46
KDM4E B2RXH2 5/20 0.46
LMNA P02545 4/20 0.46
TDP1 Q9NUW8 1/20 0.46
SMN1; SMN2 Q16637 4/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
ALOX15 P16050 1/20 0.41
CYP2C19 P33261 1/20 0.41
KMT2A Q03164 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NPC1 O15118 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13610488 0.82 TDP1 (0.43) CYP1A2CYP2D6ALDH1A1KDM4ELMNA
SCHEMBL25435114 0.81 TSHR (0.47) ALDH1A1KDM4ELMNATDP1SMN1; SMN2
SCHEMBL11337808 0.80 CYP1A2 (0.57) CYP1A2CYP2D6ALDH1A1KDM4ELMNA
SCHEMBL25435426 0.77 TSHR (0.43) ALDH1A1KDM4ELMNATDP1SMN1; SMN2
SCHEMBL13780226 0.76 SMN1; SMN2 (0.47) CYP1A2CYP2D6ALDH1A1KDM4ELMNA
SCHEMBL25384774 0.76 EHMT2 (0.50) CYP1A2CYP2D6ALDH1A1KDM4ELMNA
SCHEMBL11445226 0.75 SMN1; SMN2 (0.57) CYP1A2CYP2D6ALDH1A1KDM4ELMNA
SCHEMBL9092077 0.75 CYP1A2 (0.67) CYP1A2CYP2D6ALDH1A1KDM4ELMNA
SCHEMBL891217 0.73 TSHR (0.46) ALDH1A1KDM4ELMNATDP1SMN1; SMN2
SCHEMBL13610472 0.72 RAB9A (0.46) CYP1A2CYP2D6ALDH1A1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1742635-B1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES INC (US) 2018-03-07 EP disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-8334316-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES, INC. (US) 2012-12-18 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-7622507-B2 Substituted organosulfur compounds and methods of using thereof ACEA BIOSCIENCES INC. (US) 2009-11-24 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF ACEA BIOSCIENCES, INC. (US) 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090192146-A1 SUBSTITUTED ORGANOSULFUR COMPOUNDS AND METHODS OF USING THEREOF TST, CTH, CBS CYP1A2 3924/4885CYP2D6 2915/4885ALDH1A1 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.